Cleaning and infection control of airway clearance devices used by CF patients

被引:12
作者
Manor, Eynav [1 ,2 ]
Gur, Michal [1 ,2 ]
Geffen, Yuval [3 ]
Bentur, Lea [1 ,2 ,4 ]
机构
[1] Rambam Hlth Care Campus, Pediat Pulm Inst, Ruth Rappaport Childrens Hosp, POB 9602, IL-31092 Haifa, Israel
[2] Rambam Hlth Care Campus, CF Ctr, Ruth Rappaport Childrens Hosp, Haifa, Israel
[3] Rambam Hlth Care Campus, Microbiol Lab, Haifa, Israel
[4] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
关键词
Cleaning; cystic fibrosis; airway clearance devices; infection control; physiotherapy; GRAM-NEGATIVE BACTERIA; CYSTIC-FIBROSIS; MICROBIAL-CONTAMINATION; HOSPITAL FABRICS; NEBULIZERS; SURVIVAL; THERAPIES; ADULTS;
D O I
10.1177/1479972317707652
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Respiratory treatment for cystic fibrosis (CF) patients includes use of respiratory devices. Contamination of airway clearance devices has not been adequately explored. We aimed to determine whether airway clearance devices are contaminated after use and whether cleaning guidelines for nebulizers are as effective for airway clearance devices. Patients brought their airway clearance devices to the clinic. Swabs from the devices were taken before and after cleaning and were cultured for bacterial counts. Total colony-forming units (CFU) was determined, and predominant colonies were identified using Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry technology. Thirty devices were collected from 23 patients. Most of the devices (28/30) were contaminated when brought to the clinic. Complete bacterial eradication was achieved in 15 (50%) samples and partial eradication in 9 (30%). The cleaning was totally ineffective in four samples. Median CFU decreased significantly from 1250 (IQR 25-75% 175-10.000) to 0 (IQR 25-75% 0-700) before and after cleaning (p < 0.0001). The predominant organisms were identified in five samples only, and there was no concordance with sputum culture results. Airway clearance devices are contaminated after use, and appropriate cleaning can reduce contamination. The effect on disease progression in CF patients is unclear. There is a need for infection prevention and control guidelines for the growing number of respiratory devices.
引用
收藏
页码:370 / 376
页数:7
相关论文
共 28 条
  • [1] Treatment compliance in children and adults with Cystic Fibrosis
    Arias Llorente, Rosa Patricia
    Bousono Garcia, Carlos
    Diaz Martin, Juan Jose
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2008, 7 (05) : 359 - 367
  • [2] Microbial contamination of nebulizers in the home treatment of cystic fibrosis
    Blau, H.
    Mussaffi, H.
    Zahav, M. Mei
    Prais, D.
    Livne, M.
    Czitron, B. M.
    Cohen, H. A.
    [J]. CHILD CARE HEALTH AND DEVELOPMENT, 2007, 33 (04) : 491 - 495
  • [3] Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis: An overview of five Cochrane systematic reviews
    Bradley, JM
    Moran, FM
    Elborn, JS
    [J]. RESPIRATORY MEDICINE, 2006, 100 (02) : 191 - 201
  • [4] Cardiopulmonary, 2003, SHUR CLEAR OSC PEP T
  • [5] Managing Cystic Fibrosis Strategies That Increase Life Expectancy and Improve Quality of Life
    Cohen-Cymberknoh, Malena
    Shoseyov, David
    Kerem, Eitan
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (11) : 1463 - 1471
  • [6] Cystic fibrosis: An inherited disease affecting mucin-producing organs
    Ehre, Camille
    Ridley, Caroline
    Thornton, David J.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 52 : 136 - 145
  • [7] Adherence to Airway Clearance Therapies by Adult Cystic Fibrosis Patients
    Flores, Josani Silva
    Teixeira, Fernanda Angela
    Eidt Rovedder, Paula Maria
    Ziegler, Bruna
    Roth Dalcin, Paulo de Tarso
    [J]. RESPIRATORY CARE, 2013, 58 (02) : 279 - 285
  • [8] Flume PA, 2009, RESP CARE, V54, P522
  • [9] Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections
    Heirali, Alya
    McKeon, Suzanne
    Purighalla, Swathi
    Storey, Douglas G.
    Rossi, Laura
    Costilhes, Geoffrey
    Drews, Steven J.
    Rabin, Harvey R.
    Surette, Michael G.
    Parkins, Michael D.
    [J]. PLOS ONE, 2016, 11 (02):
  • [10] Home-use nebulizers: A potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis
    Hutchinson, GR
    Parker, S
    Pryor, JA
    DuncanSkingle, F
    Hoffman, PN
    Hodson, ME
    Kaufmann, ME
    Pitt, TL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) : 584 - 587